The Venus Times (Page 2)

The Venus Times

Sign in Subscribe

New Market Approvals: Venus Remedies Expands Cancer Care

New Market Approvals: Venus Remedies Expands Cancer Care

At Venus Remedies, our mission has always been simple but powerful: to make life-saving medicines accessible to patients wherever they are needed. In every corner of the world, people depend on safe, effective, and affordable treatments, and it is our responsibility to ensure they have access to them. Each approval

Digital Innovation in Healthcare at Venus Remedies

Digital Innovation in Healthcare at Venus Remedies

Medicines save lives, but the way we create and deliver them is always changing. At Venus Remedies, we put digital transformation at the heart of this change, helping us improve every part of healthcare. From how we do research to how medicines reach patients, technology lets us work faster, make

Venus Army: A New Era of Leadership and Impact

Venus Army: A New Era of Leadership and Impact

At Venus Remedies, every milestone reflects our commitment to progress, care, and responsibility. The Venus Army has always stood as more than just a teamâ€”it is an effort that blends innovation with compassion, serving patients, communities, and colleagues alike.This year marks a defining moment in its journey as

Venus Remedies: New Global Approvals for Life-Saving Drugs

Venus Remedies: New Global Approvals for Life-Saving Drugs

At Venus Remedies, we believe every new approval is more than just a milestoneâ€”it is a step closer to saving lives. Recently, we achieved several important global approvals that bring us closer to patients in need across the world.These approvals show our growing presence in international markets and

India's AMR Battle: MBL Inhibitors & the Road Ahead

India's AMR Battle: MBL Inhibitors & the Road Ahead

A valuable spotlight on why MBL inhibitors could be game-changing in India’s fight against superbugs and the growing threat of antimicrobial resistance.

Bendamustine Approved in Saudi Arabia | Venus Remedies

Bendamustine Approved in Saudi Arabia | Venus Remedies

Venus Remedies is honored to receive the marketing authorization for Bendamustine in Saudi Arabia, one of the strictly regulated global pharmaceutical markets. This approval is another notable addition to its extensive list of achievements and a significant step toward enhancing access to vital cancer treatments in the GCC and MENA

Excellence in HR Compliance: Award for Venus Remedies

Excellence in HR Compliance: Award for Venus Remedies

At Venus Remedies, we believe people are the foundation of every success story. When employees are supported, respected, and given the right environment, they donâ€™t just workâ€”they thrive. And when leaders invest in building strong teams, organizations naturally grow stronger.Thatâ€™s why we are proud to share

HODs Offsite Meet 2025: Growing Together at Venus

HODs Offsite Meet 2025: Growing Together at Venus

At Venus Remedies, our people are our greatest strength, and when leaders grow together, the entire organization rises with them. On 21st June 2025, this belief came to life at the HODs Offsite Meet held at the Arzoo Redwood Resort. It was a day dedicated not just to

Venus Remedies Gets Approvals from Multiple Markets

Venus Remedies Gets Approvals from Multiple Markets

Driven by innovation and a commitment to elevate global quality standards, Venus Remedies continues to break the barriers in global healthcare by securing key market authorizations.This helps the company stay aligned with its strategy as it enters new markets, upholding its quality standards and contributing to the improvement of

Microplastics & AMR: Featured in Outlook Planet:

Microplastics & AMR: Featured in Outlook Planet:

Plastic waste may be doing more than harming the environmentâ€”it may be accelerating antibiotic resistance. The article featured in Outlook Planet breaks down this critical connection.Highlighting the futuristic approach, this article by Mr. Saransh Chaudhary (CEO Venus Medicine Research Centre, Strategic Board Advisor, and President, Global

AMR Crisis Triggering Talent Loss in Healthcare

AMR Crisis Triggering Talent Loss in Healthcare

Weâ€™re proud to announce that Mr. Saransh Chaudhary, President of Global Critical Care at Venus Remedies and CEO of Venus Medicine Research Centre, has been featured in Hindustan Times.He has thrown light on an important issue in the medical world that potentially affects millions of people in the

Leading the Way in Chemotherapy Drugs: Venus Remedies

Leading the Way in Chemotherapy Drugs: Venus Remedies

The number of people suffering from one of the deadliest diseases, cancer, is increasing. This alarming change has also increased the demand for trusted chemotherapy drugs in India. However, keeping up with it has become a challenge because of the increasing number of patients and the growing demand.This has

GCC Event 2025 | Celebrating Excellence at Venus Remedies

GCC Event 2025 | Celebrating Excellence at Venus Remedies

Venus Remedies had the privilege of hosting Voice of GCC - a two day event bringing together its teams and the board of directors to reflect on achievements, align strategies, and celebrate shared success.The company has grown exponentially and expanded its global base to 96+ countries since being established

Venus Remedies Gets GMP Renewal from Ukraine SMDC

Venus Remedies Gets GMP Renewal from Ukraine SMDC

Certified once more, trusted forever. Venus Remedies has proudly secured another feather in its quality cap!In a significant boost to our global manufacturing credentials, we have successfully renewed our Good Manufacturing Practices (GMP) certification from Ukraineâ€™s State Service on Medicines and Drugs Control (SMDC). This renewal reinforces the

Venus Remedies Enhances Employee Care with Insurance Plan

Venus Remedies Enhances Employee Care with Insurance Plan

Venus Remedies has become a global name in the healthcare industry, known for its quality research-based products, enhancing the global healthcare standards. Driven by its core belief of worker centricity, the company continues to value employee welfare through persistent efforts.Their new healthcare insurance policy is in sync with their

Venus Remedies PPL 2025 Celebrates Passion & Performance

Venus Remedies PPL 2025 Celebrates Passion & Performance

Venus Remedies values its employees and nurtures an environment that motivates them to give their best.So just like the IPL, we also host our own PPL - Passion Premium League where teams compete for the winnersâ€™ cup. Each year we set the goals and let the teams devise their

Venus Remedies Partners with UNGC for Sustainable Future

Venus Remedies Partners with UNGC for Sustainable Future

Venus Remedies is proud to announce our collaboration with the United Nations Global Compact (UNGC), an initiative to support responsible and sustainable business practices worldwide. This partnership is another milestone, showing our commitment to integrating the UNGCâ€™s Ten Principles into our organization, guiding us toward a better

Venus Remedies Renews EU GMP-Expands in European Market

Venus Remedies Renews EU GMP-Expands in European Market

Venus Remedies continues its exponential growth across the globe. We are proud that as the company expands its foothold in new countries, it is also strengthening its position in the present markets. The renewal of the EU GMP by Infarmed highlights its strategy and commitment to maintain quality

Sugammadex Approved in Philippines | Venus Remedies Expands

Sugammadex Approved in Philippines | Venus Remedies Expands

Venus Remedies Ltd. has received marketing authorisation for Sugammadex in the Philippines. The addition of Sugammadex to the Philippine healthcare market aligns with the global need for safer, patient-centric surgical practices. With this, Venus Remedies continues to keep up with the market demands, reflecting its commitment to innovations

Venus Remedies Joins United Nations Global Compact

Venus Remedies Joins United Nations Global Compact

Venus Remedies has added another milestone trophy to its collection!We are proud to announce our latest membership with the United Nations Global Compact (UNGC), the world's largest corporate sustainability platform. With this collaboration, the pharmaceutical company is aligning its business operations & strategies with UNGCâ€™s

Unlocking a New Milestone: US FDA Grants QIDP Status to VRP-034!

Unlocking a New Milestone: US FDA Grants QIDP Status to VRP-034!

We are proud to share a landmark achievement in our journey at Venus Remedies Limited—one that shines a global spotlight on India’s role in tackling one of the world’s most pressing healthcare challenges: antimicrobial resistance (AMR). The U.S. Food and Drug Administration (FDA) has awarded Qualified

Venus Remedies x Infex to Combat Antimicrobial Resistance in India

Venus Remedies x Infex to Combat Antimicrobial Resistance in India

Congratulations, Venusians. We have yet again marked another day on the calendar with gold! Venus Remedies Ltd. is delighted to announce a significant partnership with UK-based anti-infective drug development company, Infex Therapeutics. The alliance aims to tackle drug-resistant Gram-negative bacterial infections via MET-X, an innovative metallo-beta-lactamase (MBL) inhibitor. Under this

Mrs. Ekta S. Chaudhary to Lead Venus Foundation

The Grand Launch Featured

Mrs. Ekta S. Chaudhary to Lead Venus Foundation

We are immensely honored and delighted to announce the appointment of Mrs. Ekta S. Chaudhary as the new Chairperson of Venus Foundation. We are certain that this significant milestone will mark a new era of growth, inclusivity, and impactful change under her visionary leadership. Her presence adds not only strength

Venus Remedies partner

Venus Remedies partners with UK-based Infex Therapeutics to develop anti-bacterial MET-X in India

Bringing a First-in-Class MBL Inhibitor to India: Venus Remedies Licenses MET-X Venus Remedies has taken a significant step in combating Antimicrobial Resistance (AMR) by securing exclusive licensing rights for MET-X, an innovative anti-bacterial drug from UK-based Infex Therapeutics. This landmark partnership will enable Venus Remedies to develop, gain regulatory approvals,

Venus Advances Its Efforts in Upgrading the Adopted School

Venus Advances Its Efforts in Upgrading the Adopted School

Venus adopted the Government Model Sanskriti Primary School in Sector 19, Panchkula, in late 2023. Since then, it has been committed to bringing substantial changes to fulfill its mission of uplifting the school, focusing on improving its infrastructure and creating a more enriching learning environment. Through its meaningful, thoughtful, and